Market Overview The Sarcoma Drugs Market includes a critical pediatric segment addressing malignancies that represent significant cancer-related mortality in children and adolescents. Pediatric sarcomas including rhabdomyosarcoma, Ewing sarcoma, and osteosarcoma require drug development approaches distinct from adult malignancies due to developmental pharmacology considerations, long-term...